Summary
Twenty-four volunteers at the Common Cold Unit were divided into two groups of twelve. One group was vaccinated orally with an enterovirus (LEV 4) and the other with nutrient broth. Both groups were challenged three days later with intranasal rhinovirus 4 and they were observed clinically and monitored by laboratory tests to see if any modification of the rhinovirus infection occurred.
All the vaccinated volunteers were successfully infected with LEV 4 and were excreting the enterovirus in the faeces at near maximum titres at the time of the rhinovirus infection, following which 67 per cent of the volunteers were infected and 29 per cent developed symptoms. However, the vaccinated group did not differ from the unvaccinated in respect of the illness induced, the excretion of rhinovirus type 4 or the rise of RV 4 antibody titre. LEV 4 was isolated from the nasopharynx of some of the volunteers, but the rhinovirus infection was not modified even in these. Interferon was present in the serum and nasal washings of nine volunteers in all, of whom only 3 had received the LEV 4 vaccination.
Two additional volunteers were shown to be insusceptible to reinfection with LEV4. It was concluded that live enterovirus vaccination does not induce viral interference.
Keywords: Infectious Disease, Interferon, Laboratory Test, Antibody Titre, Nutrient Broth
References
- 1.Tyrrell D. A. J., Reed S. E. “Non-specific” Factors influencing Host Resistance. Basel: S. Karger; 1973. Some possible practical implications of interferon and interference; pp. 438–442. [Google Scholar]
- 2.Vella P. P., Weibel R. E., Woodhour A. F., Mascoli C. C., Leagus M. B., Ittensohn O. L., Stokes J., Jr., Hilleman M. R. Respiratory virus vaccines. VIII. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families, 1967–1968. Amer. Rev. resp. Dis. 1969;99:526–541. doi: 10.1164/arrd.1969.99.4P1.526. [DOI] [PubMed] [Google Scholar]
- 3.Voroshilova M. K. Live enterovirus vaccines used as the interferon inducers for prophylaxis of respiratory infection; International Virology II; Basel: S. Karger; 1972. pp. 141–142. [Google Scholar]
- 4.Tyrrell D. A. J. The use of volunteers. Amer. Rev. resp. Dis. 1963;88:128–134. doi: 10.1164/arrd.1963.88.3P2.128. [DOI] [PubMed] [Google Scholar]
- 5.Reed S. E., Hall T. S. Haemagglutination-inhibition test in rhinovirus infections of volunteers. Infect. Immunity. 1973;8:1–3. doi: 10.1128/iai.8.1.1-3.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stott E. J., Tyrrell D. A. J. Some improved techniques for the study of rhinoviruses using HeLa cells. Arch, ges. Virusforsch. 1968;23:236–244. doi: 10.1007/BF01241896. [DOI] [PubMed] [Google Scholar]
- 7.Merigan T. C. A plaque inhibition assay for human interferon employing human neonate skin fibroblast monolayers and bovine vesicular stomatitis virus; In vitro Methods in Cell-Mediated Immunity; New York and London: Academic Press; 1971. pp. 489–497. [Google Scholar]
- 8.Zisman B. R., Merigan T. C. A useful quantitative semimicromethod for viral plaque assay. Proc. Soc. exp. Biol. Med. 1973;142:1174–1179. doi: 10.3181/00379727-142-37202. [DOI] [PubMed] [Google Scholar]
- 9.Obrosova-Serova N. P., Fedorova G. I., Glukhov P. I., Shalnov M. I., Litvinov V. G., Fadeeva L. L., Slepushkin A. N. Study on efficiency of Amantadine and interferon stimuli as means of non-specific prophylaxis of influenza. Antibiotiki (Mosk) 1972;17/8:734–738. [PubMed] [Google Scholar]
- 10.Seibil V. B., Boiko V. M., Troshina L. D., Kislenkova O. F., Bogach A. P., Tavadze T. T., Ilyna A. W., Pavlova M. A., Chacodzhiev A. M. Prophylaxis of influenza and acute respiratory diseases with the help of interferonogens. Work of the Institute of Poliomyelitis and Virus Encephalitis of the Academy of Medical Science of the U.S.S.R. 1971;16:88–100. [Google Scholar]